Einstein scientists discover cause and possible treatments for hereditary movement disorderMarch 02, 2006Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered the underlying cause of a type of ataxia, hereditary disorders characterized by poor balance, loss of posture and difficulty performing rapid coordinated movement. Their work also led to a drug that significantly improved the motor coordination in mice with ataxia-a finding that could lead to better therapies for the disease. The study appears in the March issue of Nature Neuroscience and was featured in the publication's advance online edition. The research, led by Dr. Kamran Khodakhah, associate professor in the department of neuroscience at Einstein, focused on a type of ataxia called episodic ataxia type-2. It results from gene mutations that affect calcium channels, which are involved in releasing neurotransmitters in the brain and regulating excitability in neurons. Episodic ataxia type-2 was thought to be due to impaired transmission of neurotransmitters, but the Einstein scientists suspected that something else was going on. They studied specialized cells in the brain's cerebellum called Purkinje cells, which are rich in calcium channels. Purkinje cells help coordinate movement by acting as information clearinghouses: They take in sensory and other inputs relayed to them by more than 150,000 excitatory and inhibitory synaptic inputs, combine them with the cello's own intrinsic activity or "pacemaking," and then send out the signals necessary for motor coordination.
The researchers investigated whether ataxia might be due to a reduction in the precision of the intrinsic pacemaking by Purkinje cells. Studying a number of mouse models of ataxia type-2, they found a gene-dependent loss of the precision of pacemaking in Purkinje cells, which prevented them from accurately accounting for the strength and timing of synaptic inputs when sending out signals directing muscle movement. This loss of pacemaking precision was traced to reduced activity of calcium-activated potassium channels in Purkinje cells - a direct consequence of the reduced activity of calcium channels in these disorders. Einstein researchers were able to remedy this problem with a drug called 1-ethyl-2-benzimidazolinone (EBIO). When EBIO was infused into the brains of ataxic mice, the mice's motor coordination improved significantly. "These calcium-activated potassium channels proved to be a potent therapeutic target, since chronically activating them with EBIO definitely improved the motor performance of these ataxic mice," says Dr. Khodakhah, who was senior author of the study. "We don't really have effective treatments for these types of ataxia, so we're hopeful that our findings will lead to drugs that will improve the lives of people with this condition." Dr Khodakhah has established collaborations with two neurologists, Dr Joanna Jen (UCLA) and Dr Michael Strupp (Germany) to explore the potential use of similar drugs in patients. The other Einstein researchers involved in the study were Joy T. Walter, Karina Alvina, Mary D. Womack and Carolyn Chevez. Albert Einstein College of Medicine Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Helicobacter pylori Liver Fibrosis Allergies Blood Clotting Nuclear Power Radiation Therapy Bioenergy Immunotherapy Plate Tectonics Quantum Computing HIV-1 Pre-eclampsia Emphysema Gamma-ray Burst Cancer Research Bone Formation Titanium Botox Fatigue Cancer Cells Cleft Palate Life Expectancy Hodgkin Lymphoma Dinosaurs Cosmic Dust
See More: Science News Tags | |||||||||||||||||||||
|
Related Ataxia Current Events and Ataxia News Articles Small molecules might block mutant protein production in Huntington's disease Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntington's disease, researchers at UT Southwestern Medical Center have found. LSUHSC research shows fish oil protects against diseases like Parkinson's Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans, will present new research findings showing that an omega three fatty acid in the diet protects brain cells by preventing the misfolding of a protein resulting from a gene mutation in neurodegenerative diseases like Parkinson's and Huntington's. Search for blood pressure secrets reveals a surprising new syndrome Yale researchers investigating the genetic causes of blood pressure variation have identified a previously undescribed syndrome associated with seizures, a lack of coordination, developmental delay and hearing loss. U-M researchers ID gene involved in pancreatic cancer Researchers from the University of Michigan Comprehensive Cancer Center have identified a gene that is overexpressed in 90 percent of pancreatic cancers, the most deadly type of cancer. Study: Adding Vimpat significantly reduces partial-onset seizures in adults with epilepsy The new antiepileptic drug Vimpat® (lacosamide) demonstrated significantly fewer seizures in adult partial-onset epilepsy patients whose seizures were inadequately controlled despite taking up to three other AEDs, according to a Phase III clinical study published online in Epilepsia. Research breakthrough targets genetic diseases A cure for debilitating genetic diseases such as Huntington's disease, Friedreich's ataxia and Fragile X syndrome is a step closer to reality, thanks to a recent scientific breakthrough. New step in DNA damage response in neurons discovered Researchers have identified a biochemical switch required for nerve cells to respond to DNA damage. Protein's essential role in repairing damaged cells revealed University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer. M.I.N.D. Institute researchers call for fragile X testing throughout the lifespan Writing in this week's Journal of the American Medical Association, UC Davis M.I.N.D. Institute researchers urge physicians to test for mutations of the fragile X gene in patients of all ages. International team discovers gene associated with epilepsy A University of Iowa-led international research team has found a new gene associated with the brain disorder epilepsy. More Ataxia Current Events and Ataxia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||